Division of Infectious Diseases, Johns Hopkins University School of Medicine, 600 N, Wolfe Street, Baltimore, USA.
BMC Infect Dis. 2011 Jul 15;11:193. doi: 10.1186/1471-2334-11-193.
HIV-infected and HIV-exposed, uninfected infants experience a high burden of infectious morbidity and mortality. Hospitalization is an important metric for morbidity and is associated with high mortality, yet, little is known about rates and causes of hospitalization among these infants in the first 12 months of life.
Using data from a prevention of mother-to-child transmission (PMTCT) trial (India SWEN), where HIV-exposed breastfed infants were given extended nevirapine, we measured 12-month infant all-cause and cause-specific hospitalization rates and hospitalization risk factors.
Among 737 HIV-exposed Indian infants, 93 (13%) were HIV-infected, 15 (16%) were on HAART, and 260 (35%) were hospitalized 381 times by 12 months of life. Fifty-six percent of the hospitalizations were attributed to infections; gastroenteritis was most common accounting for 31% of infectious hospitalizations. Gastrointestinal-related hospitalizations steadily increased over time, peaking around 9 months. The 12-month all-cause hospitalization, gastroenteritis-related hospitalization, and in-hospital mortality rates were 906/1000 PY, 229/1000 PY, and 35/1000 PY respectively among HIV-infected infants and 497/1000 PY, 107/1000 PY, and 3/1000 PY respectively among HIV-exposed, uninfected infants. Advanced maternal age, infant HIV infection, gestational age, and male sex were associated with higher all-cause hospitalization risk while shorter duration of breastfeeding and abrupt weaning were associated with gastroenteritis-related hospitalization.
HIV-exposed Indian infants experience high rates of all-cause and infectious hospitalization (particularly gastroenteritis) and in-hospital mortality. HIV-infected infants are nearly 2-fold more likely to experience hospitalization and 10-fold more likely to die compared to HIV-exposed, uninfected infants. The combination of scaling up HIV PMTCT programs and implementing proven health measures against infections could significantly reduce hospitalization morbidity and mortality among HIV-exposed Indian infants.
感染和未感染 HIV 的 HIV 暴露婴儿面临着较高的传染性发病率和死亡率。住院是发病率的一个重要指标,与高死亡率相关,但对于这些婴儿在生命的头 12 个月内的住院率和原因知之甚少。
使用来自预防母婴传播(PMTCT)试验(印度 SWEN)的数据,其中给予 HIV 暴露的母乳喂养婴儿延长使用奈韦拉平,我们测量了 12 个月婴儿的全因和病因特异性住院率和住院风险因素。
在 737 名印度 HIV 暴露婴儿中,93 名(13%)感染了 HIV,15 名(16%)接受了抗逆转录病毒治疗,260 名(35%)在 12 个月的生命中住院 381 次。56%的住院是由感染引起的;胃肠炎是最常见的感染性住院原因,占 31%。胃肠道相关住院率随时间稳步上升,在 9 个月左右达到峰值。12 个月的全因住院率、胃肠炎相关住院率和住院死亡率在感染 HIV 的婴儿中分别为 906/1000 人年、229/1000 人年和 35/1000 人年,而在 HIV 暴露但未感染的婴儿中分别为 497/1000 人年、107/1000 人年和 3/1000 人年。母亲年龄较大、婴儿 HIV 感染、胎龄和男性性别与全因住院风险增加相关,而母乳喂养持续时间较短和突然断奶与胃肠炎相关住院相关。
印度 HIV 暴露婴儿经历全因和感染性住院(特别是胃肠炎)和住院死亡率高。与 HIV 暴露但未感染的婴儿相比,感染 HIV 的婴儿住院的可能性几乎高出 2 倍,死亡的可能性高出 10 倍。扩大 HIV PMTCT 计划和实施针对感染的经过验证的健康措施的结合,可以显著降低印度 HIV 暴露婴儿的住院发病率和死亡率。